Search Results
Dec 04, 2025, 10:01 ET New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer's Pathobiology
to determine how therapies targeting these mechanisms can be optimized and combined to achieve greater impact for patients," said Paul Edison, MBBS, PhD, FRCPI, Professor of Neuroscience in the Faculty of Medicine at Imperial College London."With more than 70% of the Alzheimer's drug pipeline now
More news about: Alzheimer's Drug Discovery Foundation
Dec 04, 2025, 10:00 ET Cambridge Innovation Institute Releases Final Agenda and Speaker Lineup for Inaugural Women's Health Executive & Research Summit (HERS), March 23-24, 2026
professionals working on women's health each day, HERS facilitates the meetings and knowledge sharing that is necessary to address it," said Ben Lakin, PhD, CEO of Cambridge Innovation Institute, parent company of CHI.In addition to in-depth sessions for each of the three programs, HERS also offers
More news about: Cambridge Innovation Institute
Dec 04, 2025, 09:37 ET Rising Stars in Cardiac Electrophysiology: ABC Announces 2026-2027 Fellowship Recipients
MD, MPH, Beth Israel Deaconess Medical CenterChidi Amah, MD, Morehouse School of MedicineIke Royal Chinyere, MD, PhD, Sarver Heart Center, University of Arizona"These physicians represent the next generation of leaders committed to equity and innovation
More news about: Association of Black Cardiologists
Dec 04, 2025, 09:00 ET March of Dimes announces two winners of the 2025 Basil O'Connor Starter Scholar Research Awards
Awards of $150,000 each were presented to Dr. Christina Megli, MD, PhD, a high-risk obstetrician and assistant professor at the University of Pittsburgh School of Medicine, and Dr. Sarah Morton, MD, PhD, a neonatologist and assistant professor at Boston Children's Hospital.Dr. Megli's
More news about: March of Dimes
Dec 04, 2025, 09:00 ET Cumulus Neuroscience Presents Data at CTAD 2025 Annual Meeting
statistical power, and greater differentiation on clinical state and underlying disease pathology, than traditional clinic-based scales," said Brian Murphy, PhD, CSO and Co-Founder of Cumulus. "The implications are substantial. By leveraging the sensitivity of NeuLogiq measures, clinical development teams can
More news about: Cumulus Neuroscience
Dec 04, 2025, 08:45 ET Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent
profile. We believe this could represent a paradigm shift in how we manage chronic inflammatory and autoimmune conditions.'' said Dr. André P. Boulet, PhD, Chairman & CEO of Devonian.About Thykamine™Thykamine™, the first pharmaceutical product issued from Devonian's SUPREX™ platform,
More news about: Devonian Health Group Inc.
Dec 04, 2025, 08:40 ET Leaf & Mineral™ Offers the Power of Clean Cleaning for the Dirty Dishes Holiday Spike
holiday season.About Leaf & Mineral™Leaf & Mineral™ was created by a team of cleaning-industry specialists, including a PhD-level researcher in organic chemistry, dedicated to redefining what "clean" means through fact-based science and proven results. Every formula is guided
More news about: Leaf & Mineral
Dec 04, 2025, 08:36 ET Leaf & Mineral™ Is Helping Consumers Tackle the Most Time-Consuming Household Task
end of the year."About Leaf & Mineral™Leaf & Mineral™ was created by a team of cleaning-industry specialists, including a PhD-level researcher in organic chemistry, dedicated to redefining what "clean" means through fact-based science and proven results. Every formula is guided
More news about: Leaf & Mineral
Dec 04, 2025, 08:32 ET J & D Pharmaceuticals LLC Receives Orphan Drug Designation for Treatment of Hepatocellular Carcinoma (HCC)
HCC."Receiving Orphan Drug Designation is yet another significant milestone for J & D Pharmaceuticals," said Lenard Lichtenberger, PhD, Chief Scientific Officer. "This designation adds to the two previous orphan drug designations we received and continues to underscore the urgent
More news about: J & D Pharmaceuticals LLC
Dec 04, 2025, 08:30 ET Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
David Spetzler, MS, PhD, MBA.Oral Presentation:Multimodal Artificial Intelligence (AI) Models Integrating Image, Clinical, and Molecular
More news about: Caris Life Sciences
Dec 04, 2025, 08:00 ET Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
behavior-informed digital interventions – not just passive monitoring – are essential to achieving meaningful clinical impact," added Yifat Hershcovitz, PhD, Vice President of Clinical & Scientific Affairs at DarioHealth.For employers and healthcare clients, this translates into measurable value:
More news about: DarioHealth Corp.
Dec 04, 2025, 07:30 ET UofL's 2026 Grawemeyer psychology award winner recognized for contributions to autism research
delighted to have been selected for this prestigious award. It recognizes the work of the talented team with whom I work in Cambridge, including outstanding PhD and early career postdocs who have worked on these projects. I am also pleased that the Grawemeyer Award will shine a light on our research which highlights
More news about: University of Louisville
Dec 04, 2025, 07:00 ET PreciseDxⓇ Presents New Data for PreciseBreastⓇ, an AI Digital Pathology Test to Predict Breast Cancer Recurrence, at the 2025 San Antonio Breast Cancer Symposium
risk of recurrence using biopsy specimens from patients with invasive breast cancerAuthor/Presented by: Michael J. Donovan, PhD, MDPoster Presentation: Wednesday, December 10, 2025, 12:30 PM - 2:00 PMPS4-12-28: A novel approach for phenotyping triple negative
More news about: PreciseDx
Dec 04, 2025, 07:00 ET SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
behind neurodegenerative disease treatments. We are excited to channel this investment into the continued development of our pipeline," said Min Li, PhD, Founder and CEO of SciNeuro. "Our heartfelt thanks go out to our investors for their unwavering support and shared conviction in our mission. Their
More news about: SciNeuro Pharmaceuticals
Dec 04, 2025, 07:00 ET Novo Nordisk solicita aprovação da FDA para Wegovy® 7,2 mg, dose mais alta do medicamento
que vivem com obesidade, e este envio — dentro do novo programa de revisão acelerada da FDA — representa um passo empolgante", afirmou Anna Windle, PhD, vice-presidente sênior de Desenvolvimento Clínico, Assuntos Médicos e Regulatórios da Novo Nordisk. "Se aprovada, a semaglutida 7,2 mg trará a pacientes
More news about: Novo Nordisk
Dec 04, 2025, 06:00 ET InsightRX Surpasses 1,000 Hospital Deployments as the Most Widely Used AI Precision Dosing Software
real workflow needs. Our work now is to extend that foundation with agents that support clinical reasoning at scale."- Dr. Sirj Goswami, PhD, CEO and Co-Founder of InsightRXTo our early-adopters, researchers, health-system partners, and the tens of thousands of healthcare
More news about: InsightRX
Dec 04, 2025, 03:55 ET ZTE CDO Cui Li speaks at Economist Impact's AI Innovation Asia 2025
organization into an organic, adaptive one.And then we need to know how AI can truly help us. Large AI models are already performing at or beyond PhD level. While agents take a step further by integrating memory and tools, acting as the real-world application of models. And agentic AI can coordinate
More news about: ZTE Corporation
Dec 04, 2025, 03:23 ET ZTE CDO Cui Li speaks at Economist Impact's AI Innovation Asia 2025
organization into an organic, adaptive one.And then we need to know how AI can truly help us. Large AI models are already performing at or beyond PhD level. While agents take a step further by integrating memory and tools, acting as the real-world application of models. And agentic AI can coordinate
More news about: ZTE Corporation
Dec 04, 2025, 02:39 ET The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of pegcetacoplan for C3G and Primary IC-MPGN
the need for dialysis and kidney transplant, these data are a welcome advance for patients with C3G and primary IC-MPGN," said Fadi Fakhouri, M.D., PhD., Professor of Nephrology from the University of Lausanne, and lead author of the manuscript.The data published in NEJM highlights the positive
More news about: Swedish Orphan Biovitrum AB
Dec 03, 2025, 16:20 ET Marquis Who's Who Recognizes Spotlight Biographees for the Fourth Quarter of 2025
Curl-Langager, PhDProfessor Emeritus, AuthorMinot State UniversityChris FernandezChief Executive OfficerAffordable American InsuranceJoan Ava GillmanEducatorThe Browning SchoolHoward Walker Mielke, PhDAdjunct
More news about: Marquis Who's Who
Dec 03, 2025, 12:29 ET MiRus Announces First Cases with EUROPA® Posterior Cervical Fusion System with New Technology Add-on Payment (NTAP)
to instrument both C6 and C7 without having to choose which level to skip in challenging cervico-thoracic reconstructions," said Jose A. Canseco, MD, PhD, Assistant Professor of Orthopedic Surgery at Thomas Jefferson University. "It lets me avoid bulky quad-rod constructs and cumbersome connectors, which
More news about: MiRus
Dec 03, 2025, 12:00 ET Unlikely Collaborators Sponsors Free Speaker Event in Santa Monica: "Are You a Spectator to Reality? Or Are You Its Creator?" with Lisa Feldman Barrett, PhD
Feldman Barrett, PhDWhen: Wednesday, December 10, 2025. Doors open 6:00 p.m., Program 7:00 p.m. PTWhere: Unlikely Collaborators Headquarters, Santa Monica, CA + livestreamCost: Free (registration required)About Lisa Feldman Barrett, PhDLisa Feldman
More news about: Unlikely Collaborators
Dec 03, 2025, 11:00 ET Donor Network West Announces Its 2026 Rose Parade Honorees, Marking 17 Years of Participation in the Iconic New Year's Day Celebration
the Donate Life float serves as an opportunity to share stories that resonate far beyond the flowers, parade route and fanfare," said Janice Whaley, PhD., president and CEO of Donor Network West. "Every story we share at the Rose Parade represents a life forever changed. Our honorees remind the world that
More news about: Donor Network West
Dec 03, 2025, 10:42 ET Astrin Biosciences Launches Certitude™ Breast, the First Non-Imaging Breast Cancer Detection Test
Justin M. Drake, PhD, lead author of the study and Chief Science Officer at Astrin. "By identifying disease signals at the earliest stages, we can help more women benefit
More news about: Astrin Biosciences
Dec 03, 2025, 10:20 ET OneOncology and OneR Partner Practice Investigators to Present Broad Portfolio of Data at the 2025 American Society of Hematology Annual Meeting
that the OneOncology affiliated practices are bringing important research to our patients in the communities where they live" said Ian W. Flinn, MD, PhD, Chief Scientific Officer at OneOncology and leader of OneR. "These studies encompass some of the most challenging to operationalize including cellular
More news about: OneOncology, LLC.